ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,121Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 300

$1.02M Total Retail Price of All Prescriptions

Rank: 8 out of 300

566 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 566 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

34% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

5% of this provider’s 4,887 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,439 569 S3 1 1
HYDROXYCHLOROQUINE SULFATE 865 467 2 118
TIZANIDINE HCL 601 174 3 10
METHOTREXATE 446 250 4 168
ZOLPIDEM TARTRATE 440 179 5 16
MELOXICAM 395 164 6 14
PREDNISONE 386 216 7 50
TRAMADOL HCL 302 137 8 11
OXYCODONE HCL 267 75 S2 9 22
LYRICA 246 73 10 31
CYCLOBENZAPRINE HCL 224 74 R 11 35
METHADONE HCL 198 44 S2 12 25
LEVOTHYROXINE SODIUM 181 51 13 12
FENTANYL 179 46 S2 14 38
GABAPENTIN 173 54 15 6
AMITRIPTYLINE HCL 162 60 R 16 43
CYMBALTA 161 62 17 54
CARISOPRODOL 161 38 R 17 28
CELEBREX 160 138 19 114
ALLOPURINOL 143 89 20 64
ENDOCET 140 38 S2 21 60
DICLOFENAC SODIUM 135 91 22 93
OMEPRAZOLE 129 92 23 2
PROMETHAZINE HCL 121 14 R 24 58
OXYCONTIN 113 0 S2 25 37
TRAZODONE HCL 111 39 26 51
OXYCODONE HCL-ACETAMINOPHEN 109 52 S2 27 48
LEFLUNOMIDE 107 43 28 300
TOPIRAMATE 105 0 29 59
PANTOPRAZOLE SODIUM 101 23 30 45
NEXIUM 95 28 31 44
ESCITALOPRAM OXALATE 91 24 32 101
ENBREL 87 38 33 318
FLUOXETINE HCL 84 29 34 81
METHOCARBAMOL 81 28 R 35 70
LISINOPRIL 74 34 36 7
PILOCARPINE HCL 71 31 37 331
ALENDRONATE SODIUM 65 55 38 79
MORPHINE SULFATE ER 64 22 S2 39 19
TRIAMTERENE-HCTZ 59 23 40 112
LANSOPRAZOLE 59 28 40 253
POTASSIUM CHLORIDE 58 28 42 20
LEUCOVORIN CALCIUM 57 31 43 355
ATORVASTATIN CALCIUM 55 38 44 13
SERTRALINE HCL 54 22 45 40
DOXEPIN HCL 53 23 46 234
ROPINIROLE HCL 51 0 47 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.